Pharmaceutical MDL-3050 Open - Limited NYS

Chantix Litigation

IN RE: Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No. II)

17
Pending Actions
17
Total Actions Filed
0%
Resolution Rate
Active
Status
Updated 2026-05-01

Overview

The Chantix Litigation is a federal multidistrict litigation consolidated in the NYS before Katherine Polk Failla (U.S. District Judge). This MDL involves claims related to pharmaceutical issues.

As of 2026-05-01, there are 17 pending actions out of 17 total actions filed, representing a 0% resolution rate.

Who May Qualify

Eligibility for this MDL typically depends on factors such as:

  • Documented exposure to or use of the product/device in question
  • Medical diagnosis of related injuries or conditions
  • Claim filed within the applicable statute of limitations

Key Information

Assigned Judge

Katherine Polk Failla (U.S. District Judge)

District Court

NYS

MDL Number

MDL-3050

Category

Pharmaceutical

Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.